Valerie Morisset, EVP, R&D AND CSO at Eliem Therapeutics, Inc. (ELYM), sold 50,000 shares at $6.76 ($338K) on 2024-07-03, disclosed to the SEC on 2024-07-03.
Open-market sale of $338k ELYM by EVP, R&D AND CSO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ELYM | SELL | 2024-07-17 | $357K | — | Filing → |
| ELYM | SELL | 2024-07-16 | $948K | — | Filing → |
| ELYM | SELL | 2024-07-11 | $737K | — | Filing → |